Incyte Releases Rat Gem 2, Cuts Target, Adds Staff | GenomeWeb

PALO ALTO, Calif.--Incyte Pharmaceuticals released its second rat-specific Gem gene expression microarray, Rat Gem 2. The new product has more than 8,400 genes known to be active in the rat central nervous system, in addition to genes thought to be important in rat nerve functions. Researchers can use the data points resulting from Rat Gem 2 experiments to perform detailed, computer-based studies of human neurological disorders commonly modeled in laboratory rat studies, said Incyte.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.